Sarah E Scheuermann
Overview
Explore the profile of Sarah E Scheuermann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Edwards C, Karunakaran K, Garcia E, Beutler N, Gagne M, Golden N, et al.
PLoS Pathog
. 2025 Jan;
21(1):e1012456.
PMID: 39847599
The continued evolution of SARS-CoV-2 variants capable of subverting vaccine and infection-induced immunity suggests the advantage of a broadly protective vaccine against betacoronaviruses (β-CoVs). Recent studies have isolated monoclonal antibodies...
2.
Edwards C, Karunakaran K, Garcia E, Beutler N, Gagne M, Golden N, et al.
bioRxiv
. 2024 Aug;
PMID: 39109178
The continued evolution of SARS-CoV-2 variants capable of subverting vaccine and infection-induced immunity suggests the advantage of a broadly protective vaccine against betacoronaviruses (β-CoVs). Recent studies have isolated monoclonal antibodies...
3.
Melton A, Rowe L, Penney T, Krzykwa C, Goff K, Scheuermann S, et al.
Viruses
. 2024 Jul;
16(7).
PMID: 39066335
The effects of immunodeficiency associated with chronic HIV infection on COVID-19 disease and viral persistence have not been directly addressed in a controlled setting. In this pilot study, we exposed...
4.
Ellsworth C, Wang C, Katz A, Chen Z, Islamuddin M, Yang H, et al.
Viruses
. 2024 Apr;
16(4).
PMID: 38675952
This study investigates the roles of T, B, and Natural Killer (NK) cells in the pathogenesis of severe COVID-19, utilizing mouse-adapted SARS-CoV-2-MA30 (MA30). To evaluate this MA30 mouse model, we...
5.
Scheuermann S, Goff K, Rowe L, Beddingfield B, Maness N
Viruses
. 2023 Sep;
15(9).
PMID: 37766343
The ability of each new SARS-CoV-2 variant to evade host humoral immunity is the focus of intense research. Each variant may also harbor unique replication capabilities relevant for disease and...
6.
Arunachalam P, Feng Y, Ashraf U, Hu M, Walls A, Edara V, et al.
Sci Transl Med
. 2022 Aug;
14(658):eabq4130.
PMID: 35976993
Despite the remarkable efficacy of COVID-19 vaccines, waning immunity and the emergence of SARS-CoV-2 variants such as Omicron represents a global health challenge. Here, we present data from a study...
7.
Blancett L, Runge K, Reyes G, Kennedy L, Jackson S, Scheuermann S, et al.
J Fungi (Basel)
. 2021 Nov;
7(11).
PMID: 34829268
The stress response gene has been characterized in and to be involved in combating various cellular stressors, from oxidative agents to antifungal compounds. Surprisingly, the biological function of has yet...
8.
Stone A, Scheuermann S, Haile C, Cuny G, Velasquez M, Linhuber J, et al.
NPJ Vaccines
. 2021 May;
6(1):69.
PMID: 33986280
Fentanyl is a major contributor to the devastating increase in overdose deaths from substance use disorders (SUD). A vaccine targeting fentanyl could be a powerful immunotherapeutic. Here, we evaluated adjuvant...